Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma

Treatment with programmed death-1 (PD-1) blocking antibodies results in high overall response rates in refractory and relapsed classical Hodgkin lymphoma (cHL) patients, indicating that PD-1/PD-1 ligand interactions are integral to progression of this disease. Given the genetically driven increased...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Blood Cancer J
Главные авторы: Jalali, Shahrzad, Price-Troska, Tammy, Bothun, Cole, Villasboas, Jose, Kim, Hyo-Jin, Yang, Zhi-Zhang, Novak, Anne J., Dong, Haidong, Ansell, Stephen M.
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group UK 2019
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6381098/
https://ncbi.nlm.nih.gov/pubmed/30783096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-019-0185-9
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы